No gastrointestinal effects were observed pursuing acute- or intermediate-period oral publicity in rats or mice. The gastrointestinal effects have been viewed at doses resulting in serious kidney hurt or higher than doses causing liver harm. Picamilon was demonstrated to possess neuroprotective outcomes, possibly safeguarding the brain versus ag